We are live on ! Find out more
SPHS

Sophiris Bio, Inc.
SPHS

Delisted

SPHS was delisted on the 11th of March, 2020.

Back to rankings

3 hedge funds and large institutions have $71K invested in Sophiris Bio, Inc. in 2020 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

89% less funds holding

Funds holding: 27 → 3 (-24)

94% less capital invested

Capital invested by funds: $1.24M → $71K (-$1.16M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 22

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
3
Holders Change
-24
Holders Change %
-88.89%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
2
Closed
22
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$461K
2
Wells Fargo
Wells Fargo
California
-$194K
3
PAI
Palo Alto Investors
California
-$91K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$90K
5
Renaissance Technologies
Renaissance Technologies
New York
-$84K
Name Holding Trade Value Shares
Change 		Change in
Stake
HP
1
Hikari Power
Japan
$70K -$29.9K -43,420 -14%
ACM
2
AUA Capital Management
Pennsylvania
$1K -$688 -1,000 -16%
Vanguard Group
3
Vanguard Group
Pennsylvania
– -$461K -1,245,464 Closed
Wells Fargo
4
Wells Fargo
California
– -$194K -523,933 Closed
PAI
5
Palo Alto Investors
California
– -$91K -247,000 Closed
Geode Capital Management
6
Geode Capital Management
Massachusetts
– -$90K -243,523 Closed
Renaissance Technologies
7
Renaissance Technologies
New York
– -$84K -226,019 Closed
WS
8
Wedbush Securities
California
– -$33K -90,000 Closed
Northern Trust
9
Northern Trust
Illinois
– -$26K -70,600 Closed
SM
10
Sabby Management
Florida
– -$68K -42,378 Closed
PAG
11
Private Advisor Group
New Jersey
– -$15K -40,000 Closed
ACM
12
Alpha Capital Management
Texas
– -$13K -34,328 Closed
Deutsche Bank
13
Deutsche Bank
Germany
– -$6K -17,524 Closed
UBS Group
14
UBS Group
Switzerland
– -$4K -11,426 Closed
KCM
15
Kathmere Capital Management
Pennsylvania
– -$4K -10,150 Closed
LPL Financial
16
LPL Financial
California
– -$4K -10,000 Closed
Group One Trading
17
Group One Trading
Illinois
– -$2K -4,594 Closed
Morgan Stanley
18
Morgan Stanley
New York
– -$2K -4,512 Closed
PNC Financial Services Group
19
PNC Financial Services Group
Pennsylvania
– -$1K -2,500 Closed
Royal Bank of Canada
20
Royal Bank of Canada
Ontario, Canada
– -$1K -2,079 Closed
FDCDDQ
21
Federation des caisses Desjardins du Quebec
Quebec, Canada
– -$67 -182 Closed

SPHS Hedge Fund Activity: Q1 2020 in Review

3 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Sophiris Bio, Inc. (SPHS) for Q1 2020, worth a combined $71K — down 94% from $1.24M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of SPHS and 0 opened new positions — a net loss of 22 holders — while 2 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $461K sold.

  • 3 institutional investors held Sophiris Bio, Inc. (SPHS) as of Q1 2020, down from 27 in Q4 2019.
  • Funds reported $71K of Sophiris Bio, Inc. stock for Q1 2020, down 94% quarter-over-quarter.
  • 0 funds opened new Sophiris Bio, Inc. positions in Q1 2020 and 22 closed out, a net change of -22 holders.
  • The largest Sophiris Bio, Inc. seller in Q1 2020 was Vanguard Group, an estimated $461K sold.

Based on aggregated 13F filings for Q1 2020.